Sun Pharma enters into distribution services agreement with AZPIL

02 Jun 2015 Evaluate

Sun Pharmaceutical Industries has entered into a distribution services agreement with AstraZeneca Pharma India (AZPIL) for AstraZeneca’s brand ‘Axcer’, a new brand of ticagrelor, a drug used for the treatment of acute coronary syndrome (ACS).

AZPIL already has a brand under the trademark ‘Brilinta’, for ticagrelor molecule, launched and marketed by AZPIL in India since 2012.

Sun Pharma will be promoting and distributing ‘Axcer’ brand in India. This collaboration enables AstraZeneca to expand usage of this molecule through wider reach to physicians and thereby benefiting a greater number of ACS patients. It strengthens Sun Pharma’s cardiology portfolio with the addition of a new patented therapy. 


Sun Pharma Inds. Share Price

1612.15 -27.15 (-1.66%)
28-Jan-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.15
Dr. Reddys Lab 1223.65
Cipla 1315.60
Zydus Lifesciences 889.65
Lupin 2132.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×